Accueil / Tag Archives: Washington (page 30)

Tag Archives: Washington

EndoGastric Solutions Receives Positive Medical Coverage Policy by HCSC for TIF® Procedure with EsophyX® Device

Tuesday, July 5th 2016 at 1:30pm UTC Newly Issued Technology Coverage Statement on Minimally Invasive Surgical Options for GERD REDMOND, Wash.–(BUSINESS WIRE)– EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that Health Care Service Corporation (HCSC), a top commercial health insurer in …

Plus »

Omeros Corporation Announces Completion of Patient Enrollment in Pediatric Trial of OMIDRIA®

Wednesday, June 29th 2016 at 11:00am UTC — Successful Completion Expected to Lead to Additional Market Exclusivity — SEATTLE–(BUSINESS WIRE)– Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders …

Plus »

Announcement Regarding the News Coverage Concerning an Inquiry on Trades of Acucela Shares

Wednesday, June 22nd 2016 at 12:28am UTC SEATTLE–(BUSINESS WIRE)– Acucela Inc. (Tokyo:4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, announced today that during the Japan Exchange Group’s (“JPX”) regularly scheduled press event on …

Plus »

American Gastroenterological Association Releases Technology Coverage Statement on Minimally Invasive Surgical Options for GERD

Friday, June 17th 2016 at 1:00pm UTC REDMOND, Wash.–(BUSINESS WIRE)– EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the American Gastroenterological Association (AGA) has issued a Technology Coverage Statement on Minimally Invasive Surgical Options for GERD (http://www.gastro.org/practice-management/reimbursement/aga-technology-coverage-statements). Randomized controlled trial data …

Plus »

Alpine Immune Sciences Announces $48 Million Series A Financing to Support Discovery and Development of the Next Generation of Immunotherapies

Monday, June 13th 2016 at 12:30pm UTC Company will leverage its proprietary vIgD™ platform using directed evolution to create novel, multi-functional first in class immunotherapies SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc., (AIS), a privately held biotechnology company developing a next-generation immune system modulation platform, today announced the closing of its …

Plus »

Acucela Announces Termination of Emixustat Agreement and OPA-6566 Agreement with Otsuka Pharmaceutical, and Postponement of Annual Shareholder Meeting

Monday, June 13th 2016 at 10:41pm UTC SEATTLE–(BUSINESS WIRE)– Acucela Inc. (Tokyo: 4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, announced today that the Company received a written termination notice (the “Notice”) from …

Plus »

Adaptive Biotechnologies and Collaborators to Present Data Demonstrating High-Throughput Sequencing for Minimal Residual Disease (MRD) is More Sensitive Than Flow Cytometry and Can Be Used as a Determinant of Early Response to Therapy

Friday, June 10th 2016 at 9:45am UTC Data will be presented at the 21st Congress of the European Hematology Association SEATTLE–(BUSINESS WIRE)– Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, and collaborators will be presenting …

Plus »

BVGH to Host Expanded Africa Pavilion at BIO International Convention in San Francisco

Monday, June 6th 2016 at 12:01pm UTC 16 African countries will exhibit life-science capabilities along with partnership and business opportunities in growing continent economies Africa panel session will “demystify” African business opportunities for industry Jim Greenwood BIO CEO and President to officially open the Africa Pavilion SEATTLE–(BUSINESS WIRE)– BIO Ventures …

Plus »

Seattle Genetics and Astellas Present ASG-15ME and Enfortumab Vedotin Phase I Clinical Data in Metastatic Urothelial Cancer at ASCO Annual Meeting

Monday, June 6th 2016 at 12:00pm UTC -Clinical Data Indicating Antitumor Activity Presented from Two Antibody-Drug Conjugate Programs- CHICAGO & TOKYO–(BUSINESS WIRE)– Seattle Genetics, Inc. (NASDAQ:SGEN) and Astellas Pharma Inc. (TOKYO:4503) today presented first clinical data for ASG-15ME and enfortumab vedotin (ASG-22ME) at the American Society of Clinical Oncology (ASCO) …

Plus »

Juno Therapeutics’ Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes and Tolerability

Saturday, June 4th 2016 at 2:08pm UTC – Durable remissions in adult ALL, NHL, and CLL patients with JCAR014 – – 100% complete molecular remission as measured by flow cytometry in pediatric ALL patients with JCAR017 and fludarabine/cyclophosphamide – SEATTLE–(BUSINESS WIRE)– Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company focused …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.